A detailed history of Wells Fargo & Company transactions in Novavax Inc stock. As of the latest transaction made, Wells Fargo & Company holds 58,481 shares of NVAX stock, worth $536,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,481
Previous 43,147 35.54%
Holding current value
$536,855
Previous $206,000 259.22%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.89 - $20.97 $59,649 - $321,553
15,334 Added 35.54%
58,481 $740,000
Q1 2024

May 10, 2024

BUY
$3.76 - $6.02 $39,758 - $63,655
10,574 Added 32.46%
43,147 $206,000
Q4 2023

Feb 09, 2024

SELL
$4.8 - $7.67 $873,897 - $1.4 Million
-182,062 Reduced 84.82%
32,573 $156,000
Q3 2023

Nov 13, 2023

SELL
$6.81 - $9.74 $388,919 - $556,251
-57,110 Reduced 21.02%
214,635 $1.55 Million
Q2 2023

Aug 15, 2023

BUY
$6.67 - $9.52 $521,447 - $744,254
78,178 Added 40.39%
271,745 $2.02 Million
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $1.03 Million - $2.22 Million
178,161 Added 1156.44%
193,567 $1.34 Million
Q4 2022

Feb 13, 2023

SELL
$8.86 - $25.04 $12,324 - $34,830
-1,391 Reduced 8.28%
15,406 $158,000
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $42,970 - $179,719
2,361 Added 16.35%
16,797 $306,000
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $797,942 - $1.66 Million
-21,994 Reduced 60.37%
14,436 $742,000
Q1 2022

May 16, 2022

SELL
$69.73 - $142.9 $1.56 Million - $3.19 Million
-22,301 Reduced 37.97%
36,430 $2.68 Million
Q4 2021

Feb 14, 2022

BUY
$134.56 - $217.97 $751,248 - $1.22 Million
5,583 Added 10.5%
58,731 $8.4 Million
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $4.36 Million - $6.64 Million
-24,522 Reduced 31.57%
53,148 $11 Million
Q2 2021

Aug 16, 2021

SELL
$121.0 - $257.67 $1.56 Million - $3.33 Million
-12,908 Reduced 14.25%
77,670 $16.5 Million
Q1 2021

May 13, 2021

SELL
$112.98 - $319.93 $1.31 Million - $3.72 Million
-11,621 Reduced 11.37%
90,578 $16.4 Million
Q4 2020

Feb 09, 2021

SELL
$78.74 - $139.5 $3.98 Million - $7.05 Million
-50,510 Reduced 33.08%
102,199 $11.4 Million
Q3 2020

Nov 05, 2020

SELL
$79.44 - $178.51 $174,370 - $391,829
-2,195 Reduced 1.42%
152,709 $16.5 Million
Q2 2020

Aug 13, 2020

BUY
$13.86 - $83.61 $1.81 Million - $10.9 Million
130,423 Added 532.75%
154,904 $12.9 Million
Q1 2020

May 14, 2020

BUY
$3.93 - $16.0 $96,210 - $391,696
24,481 New
24,481 $333,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $718M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.